Persistence Market Research10.11.21
PET/CT systems are expected to continue to incorporate the highest clinical performance of PET as well as computed tomography (CT), and further evolve in parallel with these modalities for a long period. Constant developments in the radiopharmaceuticals used by PET/CT systems and increased government support for the research and development of these radiopharmaceuticals for medical imaging is expected to propel the PET/CT systems market during the forecast period.
According to the latest research by Persistence Market Research, the global PET/CT systems market is expected to account for more than $3 billion by the end of 2028. The PET/CT systems report also projects a significant growth potential, with an average annual growth rate pegged at 6.2 percent through 2028.
High capital investments are expected to be recovered by increased medical efficacy and patient throughput, leading to a decrease in the effective cost per image. According to various research studies, excluding additional costs, the usage of PET/CT systems is cost-efficient as these systems help avoid additional invasive procedures or imaging examinations. According to the president of Clinical Radiologists, Springfield, a new PET/CT systems costs around $2 million and a high-end CT system costs around $1 million. It costs around $600,000–$700,000 less to buy Biograph mCT, as compared to purchasing two different high-end systems.
Moreover, the device can be stored in a single room. Furthermore, PET is quite a lengthy procedure that requires transmission as well as emission scans. The fusion image by PET/CT systems was projected to result in time saving for almost about 20-30 minutes per patient, which led to a 40 percent increase in patient output. According to a research study published by National Center for Biotechnology Information, the United States, the metastases found in 16 percent of cancer patients, which was initially deemed resectable, led to cost savings amounting to $1,066 per patient with the usage of PET/CT systems.
PMR has segmented the global PET/CT systems market based on the product type, isotopes, modality, applications, end use and region. The PET/CT systems market by product type is segmented into low-range slice PET/CT systems (>20), middle range-slice PET/CT systems (21-64), high-range slice PET/CT systems (<64). By isotopes, the market for PET/CT systems is segmented into Flurodeoxyglucose, 18 F Sodium Fluoride, 62 Cu ATSM, FMISO, Thallium, Gallium, and others. By modality, the PET/CT systems market is segmented into fixed PET/CT systems and mobile PET/CT systems.
By application, the PET/CT systems market is segmented into oncology, cardiology, neurology, and others. By end use, the PET/CT systems market is segmented into hospitals, diagnostic centers, cancer research centers, and specialty clinics. The PET/CT systems market has been analyzed across all the regions of North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.
The PET/CT systems report tracks some of the key companies operating in the PET/CT systems market, which include Siemens AG; Hitachi Ltd.; Koninklijke Philips N.V.; Canon Inc.; General Electric Company; MinFound Medical Systems Co. Ltd.; and Neusoft Corporation.
According to the latest research by Persistence Market Research, the global PET/CT systems market is expected to account for more than $3 billion by the end of 2028. The PET/CT systems report also projects a significant growth potential, with an average annual growth rate pegged at 6.2 percent through 2028.
High capital investments are expected to be recovered by increased medical efficacy and patient throughput, leading to a decrease in the effective cost per image. According to various research studies, excluding additional costs, the usage of PET/CT systems is cost-efficient as these systems help avoid additional invasive procedures or imaging examinations. According to the president of Clinical Radiologists, Springfield, a new PET/CT systems costs around $2 million and a high-end CT system costs around $1 million. It costs around $600,000–$700,000 less to buy Biograph mCT, as compared to purchasing two different high-end systems.
Moreover, the device can be stored in a single room. Furthermore, PET is quite a lengthy procedure that requires transmission as well as emission scans. The fusion image by PET/CT systems was projected to result in time saving for almost about 20-30 minutes per patient, which led to a 40 percent increase in patient output. According to a research study published by National Center for Biotechnology Information, the United States, the metastases found in 16 percent of cancer patients, which was initially deemed resectable, led to cost savings amounting to $1,066 per patient with the usage of PET/CT systems.
PMR has segmented the global PET/CT systems market based on the product type, isotopes, modality, applications, end use and region. The PET/CT systems market by product type is segmented into low-range slice PET/CT systems (>20), middle range-slice PET/CT systems (21-64), high-range slice PET/CT systems (<64). By isotopes, the market for PET/CT systems is segmented into Flurodeoxyglucose, 18 F Sodium Fluoride, 62 Cu ATSM, FMISO, Thallium, Gallium, and others. By modality, the PET/CT systems market is segmented into fixed PET/CT systems and mobile PET/CT systems.
By application, the PET/CT systems market is segmented into oncology, cardiology, neurology, and others. By end use, the PET/CT systems market is segmented into hospitals, diagnostic centers, cancer research centers, and specialty clinics. The PET/CT systems market has been analyzed across all the regions of North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.
The PET/CT systems report tracks some of the key companies operating in the PET/CT systems market, which include Siemens AG; Hitachi Ltd.; Koninklijke Philips N.V.; Canon Inc.; General Electric Company; MinFound Medical Systems Co. Ltd.; and Neusoft Corporation.